Research Program: Women's Cancer
Associate Professor, Department of Obstetrics, Gynecology and Women's Health
Gynecologic Oncology Fellowship Director
Society of Gynecologic Oncologists Principal Site Investigator
Board Certified in Obstetrics and Gynecology
Board Certified in Gynecologic Oncology

judso003@umn.edu
612-626-3111, office
Preferred method of contact: e-mail

Dr. Judson's clinical profile (University of Minnesota Physicians Web site)

• Fellowship: University of North Carolina, Chapel Hill, NC; Gynecologic Oncology; July 1996 — June 1999
• Residency: University of California, San Francisco, CA; Obstetrics and Gynecology; June 1992 — June 1996
• Medical: University of Minnesota School of Medicine, Minneapolis, MN; Doctor of Medicine; September 1988 — June 1992
• College: Hamline University, St. Paul, MN; Bachelor of Science in Biology; September 1984 — June 1987
• Experience: Assistant Professor Gynecologic Oncology; University of Minnesota, Minneapolis, MN; September 1999 — present
• Director, Gynecologic Oncology North Memorial Medical Center, Robbinsdale, MN; September 1999 — present
• Fellow and Clinical Instructor, Gynecologic Oncology; University of North Carolina, Chapel Hill, NC; July 1996 — June 1999

Research Interests

1. Active research: Gynecologic Oncology Group Study #210, A Molecular Staging Study of Endometrial Carcinoma, Clinical Study Co-Chair
2. The Incidence and Treatment of Gynecologic Malignancies in Organ Transplant Recipients, Principal Investigator
3. Vulvar Cancer in Young Women, Principal Investigator
4. Outcomes in Ovarian Cancer Patients using Complementary Alternative Modalities. A Prospective, Randomized Trial; Principal Investigator
5. Hereditary Aspects of Cervical Cancer, Washington University, Co-Investigator Role of HER2 and EGFR in Endometrial Cancer, Co-Investigator

Selected Publications

Downs LS Jr, Judson PL, Argenta PA, Carson LF, Boente MP. A Phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer. Gynecol Oncol. 2004; 95:347-351.

Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF, Boente MP. Treatment and recurrence patterns in endometrial stromal sarcomas and the relationship to c-kit expression. Gynecol Oncol. 2004;95:632-636.

Argenta PA, Kubicek GJ, Dusenberry KE, Judson PL, Downs LS, Carson LF, Boente MP. Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous cervical cancer. Gynecol Oncol. 2005 May;97(2):659-661.

Mitchell SK, Carson LF, Judson P, Downs LS Jr. Efficacy and tolerability of lower dose topotecan in recurrent ovarian cancer: A retrospective case review. Int J Gynecol Cancer 2005;15:793-798.

Dusenbery KE, Potish RA, Argenta PA, Judson PL. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus. Am J Clin Oncol. 2005;28:295-300.

Jonson AL, Bliss RL, Truskinovsky A, Judson P, Argenta P, Carson L, Dusenbery K, Downs LS, Jr. Clinical features and outcomes of uterine and ovarian carcinosarcoma. Gynecol Oncol. 2006;100:561-564.

Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107:1018–1022.

Argenta PA, Ghebre R, Dusenbery KE, Chen MD, Judson PL, Downs LS Jr., Carson LF. Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-up. Eur J Gynaecol Oncol. 2006;27:231-235.

Zhang Z, Borecki I, Nguyen L, Ma D, Smith K, Huettner PC, Mutch DG, Herzog TJ, Gibb RK, Powell MA, Grigsby PW, Massad LS, Hernandez E, Judson PL, Swisher EM, Crowder S, Li J, Gerhard DS, and Rader JS. CD83 Gene Polymorphisms Increase Susceptibility to Human Invasive Cervical Cancer. Cancer Research 2007;67:(23)11202-208.

Downs LS Jr., Judson PL, Argenta PA, Ghebre R, Geller MA, Bliss RL, Boente MP, Nahhas WA, Abu-Ghazaleh SZ, Chen MD, Carson LF. A Prospective Randomized Trial of Thalidomide with Topotecan Compared to Topotecan Alone in Women with Recurrent Epithelial Ovarian Carcinoma. Cancer 2008;112(2):331-9.